Details
Title
Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
Author
Huang, Deli 1
; Tran, Jenny Tuyet 1 ; Olson, Alex 1 ; Vollbrecht, Thomas 2
; Tenuta, Mary 1
; Guryleva Mariia V 3 ; Fuller, Roberta P 4 ; Schiffner Torben 4 ; Abadejos, Justin R 1
; Couvrette Lauren 5 ; Blane, Tanya R 1 ; Saye, Karen 4 ; Li, Wenjuan 1 ; Landais Elise 6 ; Gonzalez-Martin, Alicia 7 ; Schief, William 8
; Murrell, Ben 9
; Burton, Dennis R 8
; Nemazee, David 1
; Voss, James E 1
1 The Scripps Research Institute, Department of Immunology and Microbiology, La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231)
2 The University of California San Diego, Department of Medicine, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242)
3 Karolinska Institutet, Department of Microbiology, Tumor and Cell Biology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Moscow Lomonosov State University, Faculty of Bioengineering and Bioinformatics, Moscow, Russia (GRID:grid.14476.30) (ISNI:0000 0001 2342 9668)
4 The Scripps Research Institute, Department of Immunology and Microbiology, La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231); The Scripps Research Institute, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231); The Scripps Research Institute, IAVI Neutralizing Antibody Center (IAVI), La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231)
5 The Scripps Research Institute, Department of Immunology and Microbiology, La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231); University of Ottawa, Faculty of Science, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255)
6 The Scripps Research Institute, Department of Immunology and Microbiology, La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231); The Scripps Research Institute, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231)
7 Universidad Autónoma de Madrid (UAM) and Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Department of Biochemistry, Madrid, Spain (GRID:grid.5515.4) (ISNI:0000000119578126)
8 The Scripps Research Institute, Department of Immunology and Microbiology, La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231); The Scripps Research Institute, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231); The Scripps Research Institute, IAVI Neutralizing Antibody Center (IAVI), La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231); Massachusetts Institute of Technology, and Harvard, Ragon Institute of Massachusetts General Hospital, Cambridge, USA (GRID:grid.461656.6) (ISNI:0000 0004 0489 3491)
9 Karolinska Institutet, Department of Microbiology, Tumor and Cell Biology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
; Tran, Jenny Tuyet 1 ; Olson, Alex 1 ; Vollbrecht, Thomas 2
; Tenuta, Mary 1
; Guryleva Mariia V 3 ; Fuller, Roberta P 4 ; Schiffner Torben 4 ; Abadejos, Justin R 1
; Couvrette Lauren 5 ; Blane, Tanya R 1 ; Saye, Karen 4 ; Li, Wenjuan 1 ; Landais Elise 6 ; Gonzalez-Martin, Alicia 7 ; Schief, William 8
; Murrell, Ben 9
; Burton, Dennis R 8
; Nemazee, David 1
; Voss, James E 1
1 The Scripps Research Institute, Department of Immunology and Microbiology, La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231)
2 The University of California San Diego, Department of Medicine, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242)
3 Karolinska Institutet, Department of Microbiology, Tumor and Cell Biology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Moscow Lomonosov State University, Faculty of Bioengineering and Bioinformatics, Moscow, Russia (GRID:grid.14476.30) (ISNI:0000 0001 2342 9668)
4 The Scripps Research Institute, Department of Immunology and Microbiology, La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231); The Scripps Research Institute, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231); The Scripps Research Institute, IAVI Neutralizing Antibody Center (IAVI), La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231)
5 The Scripps Research Institute, Department of Immunology and Microbiology, La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231); University of Ottawa, Faculty of Science, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255)
6 The Scripps Research Institute, Department of Immunology and Microbiology, La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231); The Scripps Research Institute, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231)
7 Universidad Autónoma de Madrid (UAM) and Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Department of Biochemistry, Madrid, Spain (GRID:grid.5515.4) (ISNI:0000000119578126)
8 The Scripps Research Institute, Department of Immunology and Microbiology, La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231); The Scripps Research Institute, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231); The Scripps Research Institute, IAVI Neutralizing Antibody Center (IAVI), La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231); Massachusetts Institute of Technology, and Harvard, Ragon Institute of Massachusetts General Hospital, Cambridge, USA (GRID:grid.461656.6) (ISNI:0000 0004 0489 3491)
9 Karolinska Institutet, Department of Microbiology, Tumor and Cell Biology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
Publication year
2020
Publication date
2020
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2473298976
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.